Literature DB >> 3319506

Mechanisms of resistance to cephalosporin antibiotics.

D M Livermore1.   

Abstract

Cephalosporins, like other beta-lactams, bind to the bacterial penicillin-binding proteins (PBPs). These correspond to the D-ala-D-ala trans-, carboxy- and endo-peptidases responsible for catalysing the cross-linking of newly formed peptidoglycan. Resistance arises when the PBPs-and particularly the transpeptidases-are modified, or when they are protected by beta-lactamases or 'permeability barriers'. Target-mediated cephalosporin resistance can involve either reduced affinity of an existing PBP component, or the acquisition of a supplementary beta-lactam-insensitive PBP. beta-lactamases are produced widely by bacteria and may be determined by chromosomal or plasmid DNA. The chromosomal beta-lactamases are species-specific, but can be classified into a few broad groups. The plasmid-mediated enzymes cross interspecific and intergeneric boundaries. The level of beta-lactamase-mediated resistance relates to the amount of enzyme produced with or without induction; to the location of the enzyme (extracellular for Gram-positive organisms and periplasmic in Gram-negative ones); and to the kinetics of the enzyme's activity. In Gram-positive organisms the PBPs are located on the outer aspect of the cytoplasmic membrane and so shielding by permeability barriers is minimal. In Gram-negative cells, however, the PBPs are protected by the outer membrane, which most beta-lactams cross by diffusion through aqueous pores composed of 'porin' proteins. In enterobacteria, a clear correlation exists between porin quantity and cephalosporin resistance, suggesting that the outer membrane is the sole barrier to drug entry. Such relationships are less clear for Pseudomonas aeruginosa, where the cell may contain additional barriers between the outer membrane and the PBPs. Although elevated cephalosporin resistance often is attributed to a single factor (PBP-modification, beta-lactamase action or impermeability) an organism's response to a drug often reflects the interplay of several factors. Mathematical models can be proposed to describe this interplay.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319506     DOI: 10.2165/00003495-198700342-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  122 in total

1.  Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01.

Authors:  R E Hancock; G M Decad; H Nikaido
Journal:  Biochim Biophys Acta       Date:  1979-07-05

2.  Mechanisms of resistance to cephalosporins in ampicillin-resistant Escherichia coli.

Authors:  A A Medeiros; T F O'brien
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

3.  Synergism between beta-lactam antibiotics: a test of theoretical predictions made with Staphylococcus aureus.

Authors:  J M Hamilton-Miller; J Ramsay
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

Review 4.  Mode of action of beta-lactam antibiotics.

Authors:  D J Tipper
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

5.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

6.  Purification and some properties of a cephalosporinase from Proteus vulgaris.

Authors:  N Matsubara; A Yotsuji; K Kumano; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 7.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.

Authors:  D M Livermore; Y J Yang
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

9.  Detection of PSE-2 beta-lactamase in enterobacteria.

Authors:  D M Livermore; J P Maskell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

10.  Quantitative correlation between penicillin resistance and beta-lactamase activity specified by the R plasmids R1, R1 bla-45, and RP1 in Escherichia coli K-12.

Authors:  I Crowlesmith; T G Howe
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more
  15 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Class I beta-lactamases. Induction and derepression.

Authors:  I Phillips; K Shannon
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 3.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Authors:  S Y Essack
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 5.  Use of cephalosporins in the immunologically compromised patient.

Authors:  A C Newland; H Gaya
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

Authors:  Narisara Chantratita; Drew A Rholl; Bernice Sim; Vanaporn Wuthiekanun; Direk Limmathurotsakul; Premjit Amornchai; Aunchalee Thanwisai; Hui Hoon Chua; Wen Fong Ooi; Matthew T G Holden; Nicholas P Day; Patrick Tan; Herbert P Schweizer; Sharon J Peacock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

8.  Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB.

Authors:  Alessio Atzori; Giuliano Malloci; Jigneshkumar Dahyabhai Prajapati; Andrea Basciu; Andrea Bosin; Ulrich Kleinekathöfer; Jürg Dreier; Attilio V Vargiu; Paolo Ruggerone
Journal:  J Phys Chem B       Date:  2019-05-28       Impact factor: 2.991

Review 9.  Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.

Authors:  E Strehl; F Kees
Journal:  Drugs       Date:  2000       Impact factor: 9.546

10.  Antimicrobial Susceptibilities and Distribution of Resistance Genes for β-Lactams in Streptococcus pneumoniae Isolated in Hamadan.

Authors:  Mohammad Najafi Mosleh; Marzieh Gharibi; Mohammad Yousef Alikhani; Massoud Saidijam; Giti Kalantarian
Journal:  Jundishapur J Microbiol       Date:  2014-10-01       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.